Ackerman, M. E. Et Al. 2013. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. JOURNAL OF CLINICAL INVESTIGATION , vol.123, no.5 , 2183-2192.

Ackerman, M. E., Crispin, M., Yu, X., Baruah, K., Boesch, A. W., Harvey, D. J., ... Dugast, A.(2013). Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. JOURNAL OF CLINICAL INVESTIGATION , vol.123, no.5, 2183-2192.

Ackerman, Margaret Et Al. "Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity," JOURNAL OF CLINICAL INVESTIGATION , vol.123, no.5, 2183-2192, 2013

Ackerman, Margaret E. Et Al. "Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity." JOURNAL OF CLINICAL INVESTIGATION , vol.123, no.5, pp.2183-2192, 2013

Ackerman, M. E. Et Al. (2013) . "Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity." JOURNAL OF CLINICAL INVESTIGATION , vol.123, no.5, pp.2183-2192.

@article{article, author={Margaret E. Ackerman Et Al. }, title={Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity}, journal={JOURNAL OF CLINICAL INVESTIGATION}, year=2013, pages={2183-2192} }